Nisso America, Inc. and Mutchler Pharmaceutical Ingredients, Inc. announced their co-marketing and distribution partnership for Nisso HPC (hydroxypropyl cellulose), a highly efficient excipient used in the pharmaceutical industry as a tablet binder, film coating, controlled release polymer, and to enable solubility enhancement through solid dispersions and nano-milling. Hiroyasu Yamazaki, President of Nisso America said, “A partnership with the technical sales team of Mutchler will help us to better communicate with pharmaceutical formulators about the unique advantages Nisso HPC can provide to solve difficult formulation problems.”
Mutchler, Inc. has been serving the Pharmaceutical Industry since 1947 as a distributor of excipients with the highest levels of quality and service. “The partnership with Nisso is a complimentary addition to the Mutchler portfolio of high-quality, high-functionality excipients,” said Dwight Mutchler, President of Mutchler, Inc. “Mutchler will provide sales, marketing, sampling, technical support, and distribution for Nisso HPC to the pharmaceutical market in the USA and Puerto Rico.
About Nippon Nisso America, Inc.
Nisso America, Inc is based in New York City and is a wholly owned subsidiary of Nippon Soda Co., Ltd. (NISSO) of Tokyo, Japan. Nisso has a long history in the HPC market. 2017 will mark the 50th anniversary of the first HPC production; in 2020, the company will celebrate its 100th anniversary. The long-term vision called “Chemigress to 100” represents the Company’s ambition of “contributing to the sound development of society with the strength of chemistry.”
For more information, please contact: